Evidence map›Paper›PMID 25713380›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs.

Eric Londin, Phillipe Loher, Aristeidis G Telonis, Kevin Quann, Peter Clark, Yi Jing, Eleftheria Hatzimichael, Yohei Kirino, Shozo Honda, Michelle Lally and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 2 pooled it
27.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 2 syntheses or guidelines pooled it, 414 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. In silico unwinding ofRNA biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 12 institutions in 4 countries.

Eric LondinComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Phillipe LoherComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Aristeidis G TelonisComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Kevin QuannComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Peter ClarkComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Yi JingComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Eleftheria HatzimichaelComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107; Department of Hematology, University Hospital of Ioannina, Ioannina, GR-45500, Greece;
Yohei KirinoComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Shozo HondaComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Michelle LallyDepartment of Medicine, Rhode Island and Miriam Hospitals, Alpert Medical School of Brown University, Providence, RI 02912;
Bharat RamratnamDepartment of Medicine, Rhode Island and Miriam Hospitals, Alpert Medical School of Brown University, Providence, RI 02912;
Clay E S ComstockAmerican Association of Cancer Research, Philadelphia, PA 19106;ORCID http://orcid.org/0000-0001-5867-1489
Karen E KnudsenDepartment of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
Leonard GomellaDepartment of Urology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
George L SpaethGlaucoma Service, Wills Eye Institute, Philadelphia, PA 19107;
Lisa HarkGlaucoma Service, Wills Eye Institute, Philadelphia, PA 19107;
L Jay KatzGlaucoma Service, Wills Eye Institute, Philadelphia, PA 19107;
Agnieszka WitkiewiczDepartment of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235;
Abdolmohamad RostamiDepartment of Neurology, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Sergio A JimenezJefferson Institute of Molecular Medicine and The Scleroderma Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Michael A HollingsworthDepartment of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198;
Jen Jen YehDepartments of Surgery and Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27514;
Chad A ShawDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030;
Steven E McKenzieCardeza Foundation for Hematologic Research, Division of Hematology, Department of Medicine, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Paul BrayCardeza Foundation for Hematologic Research, Division of Hematology, Department of Medicine, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107;
Peter T NelsonDepartment of Pathology, Division of Neuropathology, Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506;
Simona ZupoMolecular Diagnostic Laboratory, Pathology Department, Istituto di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera Universitaria San Martino IST, Genoa, Italy;
Katrien Van RoosbroeckDepartment of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
Michael J KeatingLeukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
George A CalinLeukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX 77030;
Charles YeoDepartment of Surgery, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia PA 19107;
Masaya JimboDepartment of Surgery, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia PA 19107;
Joseph CozzitortoDepartment of Surgery, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia PA 19107;
Jonathan R BrodyDepartment of Surgery, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia PA 19107;
Kathleen DelgrossoCancer Genomics Laboratory, Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
John S MattickGarvan Institute of Medical Research, Sydney NSW 2010, Australia; and St. Vincent's Clinical School and School of Biotechnology & Biomolecular Sciences, University of New South Wales, Sydney NSW 2052, Australia.
Paolo FortinaCancer Genomics Laboratory, Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107;
Isidore RigoutsosComputational Medicine Center, Sidney Kimmel Medical School at Thomas Jefferson University, Philadelphia, PA 19107; Isidore.Rigoutsos@jefferson.edu.
Thomas Jefferson University · USThe University of Texas MD Anderson Cancer Center · USWills Eye Hospital · USBrown University · USAmerican Association For Cancer Research · USBaylor College of Medicine · USGarvan Institute of Medical Research · AUOspedale Policlinico San Martino · ITThe University of Texas Southwestern Medical Center · USUniversity of Kentucky · USUniversity of Nebraska Medical Center · USUniversity of North Carolina at Chapel Hill · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI CHRISTINE M. EISCHEN · 1995 to 2026
$94.8M
UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Steven H Caplan · 1985 to 2026
$55.0M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Supplement - Inflammatory Triggers in B Cell AutoimmunityU19AI056363 · NIAID · DUKE UNIVERSITY · PI ST. CLAIR, EUGENE WILLIAM · 2003 to 2017
$35.3M
University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
Tissue CoreP50CA127297 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SINGH, PANKAJ KUMAR · 2008 to 2018
$17.1M
Variation in platelet function: the genetics of platelet gene expressionR01HL102482 · NHLBI · UNIVERSITY OF UTAH · PI BRAY, PAUL F. · 2010 to 2018
$4.6M
BIOCHEMICAL AND VASCULAR ALTERATIONS IN SCLERODERMAR01AR019616 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI JIMENEZ, SERGIO A · 1986 to 2010
$3.2M
piRNA biogenesis ruled by PIWI-TUDOR interactionR01GM106047 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI KIRINO, YOHEI · 2013 to 2022
$2.8M
Cyclin D1: repercussions of AR control and alternative splicing in prostate canceR01CA099996 · NCI · UNIVERSITY OF CINCINNATI · PI KNUDSEN, KAREN E · 2003 to 2013
$2.6M
Genetic regulation of racial differences in platelet reactivityR01MD007880 · NIMHD · UNIVERSITY OF UTAH · PI BRAY, PAUL F. · 2013 to 2017
$1.9M
NCI NIH HHS CA140424NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA036727NCI NIH HHS P30 CA056036NCI NIH HHS P50 CA127297NCI NIH HHS R01 CA099996NCI NIH HHS R01 CA140424NHLBI NIH HHS R01 HL102482NHLBI NIH HHS R01 HL116713NIAID NIH HHS 2U19-AI056363-06/20309840NIAID NIH HHS P30 AI042853NIAMS NIH HHS R01 AR019616NIAMS NIH HHS R01 AR 19616NIA NIH HHS AG028383NIA NIH HHS AG042419NIA NIH HHS P30 AG028383NIA NIH HHS R01 AG042419NIGMS NIH HHS GM106047NIGMS NIH HHS R01 GM106047NIMHD NIH HHS R01 MD007880NINDS NIH HHS NS085830NINDS NIH HHS R21 NS085830
6 · The paper itself

Abstract

Two decades after the discovery of the first animal microRNA (miRNA), the number of miRNAs in animal genomes remains a vexing question. Here, we report findings from analyzing 1,323 short RNA sequencing samples (RNA-seq) from 13 different human tissue types. Using stringent thresholding criteria, we identified 3,707 statistically significant novel mature miRNAs at a false discovery rate of ≤ 0.05 arising from 3,494 novel precursors; 91.5% of these novel miRNAs were identified independently in 10 or more of the processed samples. Analysis of these novel miRNAs revealed tissue-specific dependencies and a commensurate low Jaccard similarity index in intertissue comparisons. Of these novel miRNAs, 1,657 (45%) were identified in 43 datasets that were generated by cross-linking followed by Argonaute immunoprecipitation and sequencing (Ago CLIP-seq) and represented 3 of the 13 tissues, indicating that these miRNAs are active in the RNA interference pathway. Moreover, experimental investigation through stem-loop PCR of a random collection of newly discovered miRNAs in 12 cell lines representing 5 tissues confirmed their presence and tissue dependence. Among the newly identified miRNAs are many novel miRNA clusters, new members of known miRNA clusters, previously unreported products from uncharacterized arms of miRNA precursors, and previously unrecognized paralogues of functionally important miRNA families (e.g., miR-15/107). Examination of the sequence conservation across vertebrate and invertebrate organisms showed 56.7% of the newly discovered miRNAs to be human-specific whereas the majority (94.4%) are primate lineage-specific. Our findings suggest that the repertoire of human miRNAs is far more extensive than currently represented by public repositories and that there is a significant number of lineage- and/or tissue-specific miRNAs that are uncharacterized.

Indexed as

AnimalsBase SequenceGene Knockdown TechniquesGenomeMicroRNAsPrimatesRibonuclease IIISequence AlignmentMicroRNAsRibonuclease IIIisomIRsmicroRNAsnoncoding RNARNA sequencingtranscriptome

Identifiers

PMID25713380
PMCPMC4364231
OpenAlexW2022326327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.